Verve Therapeutics Stock Soars 76% on $1.3B Buyout Offer From Lilly

• click to rate

  Posted by Two Blokes Jun 17 - Filed in Stock - 6 views
  
  VERV jumps on Eli Lilly's buyout offer, adding next-gen gene-editing therapies to the pharma giant's pipeline.